AllianceBernstein
BRLI

AllianceBernstein’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

AllianceBernstein’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-51,434
Closed -$2.12M – 3042
2015
Q2 		$2.12M Buy
51,434
+9,900
+24% +$355K ﹤0.01% 1744
2015
Q1 		$1.46M Sell
41,534
-2,400
-5% -$81.2K ﹤0.01% 1953
2014
Q4 		$1.41M Sell
43,934
-7,300
-14% -$211K ﹤0.01% 1979
2014
Q3 		$1.44M Sell
51,234
-2,400
-4% -$73.1K ﹤0.01% 1960
2014
Q2 		$1.62M Sell
53,634
-96
-0.2% -$2.65K ﹤0.01% 1936
2014
Q1 		$1.49M Buy
53,730
+60
+0.1% +$1.57K ﹤0.01% 1917
2013
Q4 		$1.37M Buy
53,670
+610
+1% +$18.8K ﹤0.01% 1973
2013
Q3 		$1.58M Sell
53,060
-49
-0.1% -$1.36K ﹤0.01% 1844
2013
Q2 		$1.53M Buy
+53,109
New +$1.46M ﹤0.01% 1810

Other funds holding BRLI

SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

AllianceBernstein's BRLI Position: Q3 2015 in Review

AllianceBernstein sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 51,434 shares — an estimated $2.12M sold.

AllianceBernstein first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $2.12M in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • AllianceBernstein reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • AllianceBernstein sold 51,434 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $2.12M.
  • AllianceBernstein first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
  • AllianceBernstein's BIO-REFERENCE LABS INC-NEW- position peaked at $2.12M in Q2 2015.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on AllianceBernstein's 13F filing for Q3 2015, filed 13 Nov 2015.